Axel Semjonow

发表

Clinical map document based on XML (cMDX): document architecture with mapping feature for reporting and analysing prostate cancer in radical prostatectomy specimens

Martin Dugas, Okyaz Eminaga, Reemt Hinkelammert, 2010, BMC Medical Informatics Decis. Mak..

The need for harmonized structured documentation and chances of secondary use - Results of a systematic analysis with automated form comparison for prostate and breast cancer

Martin Dugas, Thomas Bürkle, Bernhard Breil, 2014, J. Biomed. Informatics.

HIS-based electronic documentation can significantly reduce the time from biopsy to final report for prostate tumours and supports quality management as well as clinical research

Martin Dugas, Bernhard Breil, Axel Semjonow, 2009, BMC Medical Informatics Decis. Mak..

HIS-based Kaplan-Meier plots - a single source approach for documenting and reusing routine survival information

Fleur Fritz, Martin Dugas, Bernhard Breil, 2011, BMC Medical Informatics Decis. Mak..

CMDX©-based single source information system for simplified quality management and clinical research in prostate cancer

Okyaz Eminaga, Reemt Hinkelammert, Axel Semjonow, 2012, BMC Medical Informatics and Decision Making.

Linkage of Data from Diverse Data Sources (LDS): A Data Combination Model Provides Clinical Data of Corresponding Specimens in Biobanking Information System

Sebastian Wille, Okyaz Eminaga, Axel Semjonow, 2013, Journal of Medical Systems.

PROCEEDINGS OF THE 16th INTERNATIONAL HAMBURG SYMPOSIUM ON TUMOR MARKERS

Catharine M. Sturgeon, P. Molina, Axel Semjonow, 2016 .

Diagnosis of Prostate Cancer—The Clinical Use of Prostate Specific Antigen

Catharine M. Sturgeon, Axel Semjonow, C. Sturgeon, 2003 .

Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis.

Klaus Jung, Arndt Hartmann, Axel Semjonow, 2007, The Journal of urology.

Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsies.

Klaus Jung, Henning Cammann, Carsten Stephan, 2002, Clinical chemistry.

Clinical staging error in prostate cancer: localization and relevance of undetected tumour areas

Axel Semjonow, Peter Alken, Christel Weiss, 2009, BJU international.

Twenty Years of PSA: From Prostate Antigen to Tumor Marker.

Axel Semjonow, A. Semjonow, Stephen D Mikolajczyk, 2007, Reviews in urology.

Active surveillance for low-risk prostate cancer.

Ewout W Steyerberg, Guido Jenster, Antti Rannikko, 2013, Critical reviews in oncology/hematology.

Combination possibility and deep learning model as clinical decision-aided approach for prostate cancer

Okyaz Eminaga, Bernhard Breil, Axel Semjonow, 2020, Health Informatics J..